Smith Mark Alan 4
4 · VistaGen Therapeutics, Inc. · Filed Jan 3, 2022
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2021-12-31$1.66/sh+2,655$4,401→ 14,915 total
Footnotes (1)
- [F1]Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)